uveal melanoma
Showing 2476 - 2500 of 2,548
Advanced Melanoma, Untreated Patients Trial in Beijing (dacarbazine plus Endostar (Experimental group), dacarbazine plus
Unknown status
- Advanced Melanoma
- Untreated Patients
- dacarbazine plus Endostar (Experimental group)
- dacarbazine plus placebo (control group)
-
Beijing, Beijing, ChinaBeijing tumor hospital
Dec 6, 2009
The Identification of Novel Prognostic Markers in Melanoma
Unknown status
- Malignant Melanoma
-
Sutton, Surrey, United KingdomRoyal Marsden NHS Foundation Trust
Oct 26, 2009
Intraoperative Gamma Camera Imaging During Sentinel Node Biopsy
Completed
- Melanoma
-
Charlottesville, VirginiaUniversity of Virginia Health System
Oct 20, 2009
Peripheral Blood and/or Bone Marrow, Including Detection of
Completed
- Melanoma
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Oct 1, 2009
Intraoperative Mapping of Regional Lymphatics Draining Primary
Completed
- Melanoma
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Sep 14, 2009
Melanoma, Malignant Melanoma Trial in Nashville (lovastatin, interferon alfa-2b)
Withdrawn
- Melanoma
- Malignant Melanoma
- lovastatin
- interferon alfa-2b
-
Nashville, TennesseeNeoPlas Innovation
Sep 4, 2009
Melanoma Stage III or IV Trial in Nijmegen (autologous dendritic cell vaccine)
Completed
- Melanoma Stage III or IV
- autologous dendritic cell vaccine
-
Nijmegen, PO Box 9101, NetherlandsRadboud University Nijmegen Medical Center
Sep 28, 2009
Uveal Melanoma Trial in St. Louis (Intraoperative ultrasonography)
Unknown status
- Uveal Melanoma
- Intraoperative ultrasonography
-
St. Louis, MissouriWashington University in St. Louis School of Medicine
May 6, 2008
Metastatic Renal Cell Carcinoma, Metastatic Malignant Melanoma Trial in Auckland, Hamilton, London (AS1409)
Completed
- Metastatic Renal Cell Carcinoma
- Metastatic Malignant Melanoma
-
Auckland, New Zealand
- +3 more
Aug 24, 2009
Stage III or Stage IV Melanoma Trial in Allentown (CADI-05)
Terminated
- Stage III or Stage IV Melanoma
- CADI-05
-
Allentown, PennsylvaniaLehigh Valley Hospital
Jun 10, 2009
Malignant Melanoma Trial in Worldwide (Dacarbazine + Interferon alpha + Thymosin-alpha-1 1.6 mg, Dacarbazine + Interferon alpha
Completed
- Malignant Melanoma
- Dacarbazine + Interferon alpha + Thymosin-alpha-1 1.6 mg
- +4 more
-
La Tronche, France
- +63 more
Jul 1, 2009
Melanoma Tumors Trial in United Kingdom, United States (KU-0059436 (AZD2281)(PARP inhibitor), dacarbazine)
Completed
- Melanoma Neoplasms
- KU-0059436 (AZD2281)(PARP inhibitor)
- dacarbazine
-
Pittsburgh, Pennsylvania
- +3 more
May 14, 2009
Metastatic Melanoma Trial in Kuopio, Oulu, Tampere (Bevacizumab (Avastin), dacarbazine, interferon-alfa-2a (Roferon-A))
Completed
- Metastatic Melanoma
- Bevacizumab (Avastin)
- +2 more
-
Kuopio, Finland
- +2 more
Apr 2, 2009
Colorectal Tumors Trial in Hellerup (MelCancerVac)
Completed
- Colorectal Neoplasms
- MelCancerVac
-
Hellerup, DenmarkSurgical Department, University Hospital Gentofte
Feb 17, 2009
Melanoma, Kidney Tumors, Metastases Trial in Ann Arbor, Seattle (Recombinant Human Interleukin-21)
Completed
- Melanoma
- +2 more
- Recombinant Human Interleukin-21
-
Ann Arbor, Michigan
- +1 more
Mar 6, 2009
Melanoma (Skin) Trial in Worldwide (GM2-KLH vaccine, QS21, adjuvant therapy)
Unknown status
- Melanoma (Skin)
- GM2-KLH vaccine
- +2 more
-
Perth, Western Australia, Australia
- +79 more
Feb 6, 2009
Carcinoma, Melanoma Trial (CPG 7909 Injection, dacarbazine, Chemotherapy)
Completed
- Carcinoma, Melanoma
- CPG 7909 Injection
- +2 more
- (no location specified)
Feb 9, 2009
Melanoma Stage III or IV Trial in Nijmegen (Peptide-pulsed dendritic cells)
Completed
- Melanoma Stage III or IV
- Peptide-pulsed dendritic cells
-
Nijmegen, PO Box 9101, NetherlandsRadboud University Nijmegen Medical Centre
Feb 18, 2009
Metastatic Malignant Melanoma Trial in San Francisco (Temozolomide and SU11248)
Terminated
- Metastatic Malignant Melanoma
- Temozolomide and SU11248
-
San Francisco, CaliforniaNorthern California Melanoma Center
Feb 3, 2009
Melanoma (Skin) Trial in Boston (autologous dendritic cell-tumor fusion vaccine, gp100 antigen, therapeutic autologous dendritic
Unknown status
- Melanoma (Skin)
- autologous dendritic cell-tumor fusion vaccine
- +2 more
-
Boston, Massachusetts
- +2 more
Feb 6, 2009
Uveal Melanoma, Radiation Retinopathy, Radiation Maculopathy Trial in Philadelphia (Ranibizumab)
Unknown status
- Uveal Melanoma
- +2 more
-
Philadelphia, PennsylvaniaWills Eye Institute
Oct 5, 2007